# A Novel Non-Invasive Acoustic Diagnostic for the Diagnosis of Coronary Artery Disease The CAD-det Validation Study

Study · id `cardio:ct-nct04562142` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04562142](<https://clinicaltrials.gov/study/NCT04562142>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04562142

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 395 participants.

## Technical summary

Registry record NCT04562142. Allocation not applicable; no masking; primary purpose other. Start 2021-03 (anticipated); primary completion 2022-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 395 participants (planned count; ClinicalTrials.gov record NCT04562142, source copy `cardio:ctgov-nct04562142-2020-09-24`, retrieved 2026-10-26)
- Planned start: 2021-03 (anticipated) (ClinicalTrials.gov record NCT04562142, source copy `cardio:ctgov-nct04562142-2020-09-24`, retrieved 2026-10-26)
- Primary completion: 2022-03 (anticipated) (ClinicalTrials.gov record NCT04562142, source copy `cardio:ctgov-nct04562142-2020-09-24`, retrieved 2026-10-26)
- Completion: 2022-05 (anticipated) (ClinicalTrials.gov record NCT04562142, source copy `cardio:ctgov-nct04562142-2020-09-24`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT04562142, source copy `cardio:ctgov-nct04562142-2020-09-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04562142-2020-09-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Novel Non-Invasive Acoustic Diagnostic for the Diagnosis of Coronary Artery Disease The CAD-det Validation Study
- Condition: Coronary Artery Disease
- Condition: Cardiovascular Diseases
- Condition: Atherosclerosis
- Condition: Coronary Occlusion
- Intervention (Device): CAD-det
- Lead sponsor: AusculSciences Canada Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: Ottawa Heart Institute Research Corporation
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as a collaborator: Ottawa Heart Institute Research Corporation (`cardio:org-ottawa-heart-institute-research-corporation`)

## Provenance

Content hash: 6b66179781324f7b4dd3617e2322f73798b8c2ec6a1dc41f3242eccac60e49c9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
